MicroRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases

Cellular and Molecular Life Sciences

Volumn 73, Issue 4, 2016, Pages 811-827

  Basak, Indranil ^a   Patil, Ketan S ^a   Alves, Guido ^b   Larsen, Jan Petter ^b   Møller, Simon Geir ^a,b  

^a ST JOHN'S UNIVERSITY   (United States)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Biomarker; Body fluid; microRNA; microRNA technological advancements; Neurodegenerative diseases; Therapeutic agent; Tissue enriched

Indexed keywords

BIOLOGICAL MARKER; LEVODOPA; MICRORNA; MICRORNA 101; MICRORNA 106; MICRORNA 124A; MICRORNA 132; MICRORNA 134; MICRORNA 137; MICRORNA 148A; MICRORNA 15A; MICRORNA 17 5P; MICRORNA 181C; MICRORNA 184; MICRORNA 185; MICRORNA 188 5P; MICRORNA 198; MICRORNA 210; MICRORNA 224; MICRORNA 26B; MICRORNA 29A; MICRORNA 338 3P; MICRORNA 342 3P; MICRORNA 373; MICRORNA 490; MICRORNA 548D; MICRORNA 9; MICRORNA LET 7B; NEUROTRANSMITTER; UNCLASSIFIED DRUG; UNINDEXED DRUG; GENETIC MARKER;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; BIOGENESIS; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; SCRAPIE; SHY DRAGER SYNDROME; TRINUCLEOTIDE REPEAT DISORDER; ANIMAL; BRAIN; DRUG DEVELOPMENT; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC MARKER; GENETICS; METABOLISM; NEURODEGENERATIVE DISEASES; PATHOLOGY;

ANIMALS; AUTOPHAGY; BRAIN; DRUG DISCOVERY; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENETIC THERAPY; HUMANS; MICRORNAS; NEURODEGENERATIVE DISEASES; TRANSCRIPTION, GENETIC;

EID: 84957438262     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-015-2093-x     Document Type: Review

References (155)

1. International Human Genome Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409:860-921
2. Huttenhofer A, Schattner P, Polacek N (2005) Non-coding RNAs: hope or hype? Trends Genet 21:289-297
3. Kaikkonen MU, Lam MT, Glass CV (2011) Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 90:430-440
4. Ardekani AM, Naeini MM (2010) The role of microRNAs in human diseases. Avicenna J Med Biotechnol 2:161-179
5. Li Y, Kowdley KV (2012) MicroRNAs in common human diseases. Genomics Proteomics Bioinform 10:246-253
6. Etheridge A, Lee I, Hood L, Galas D, Wang K (2011) Extracellular microRNA: a new source of biomarker. Mutat Res 717:85-90
7. Jeffrey SS (2008) Cancer biomarker profiling with microRNAs. Nat Biotechnol 26:400-401
8. Goodall EF, Heath PR, Bandmann O, Kirby J, Shaw PJ (2013) neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Front Cell Neurosci 7:178
9. Cathew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655
10. Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126-139
11. Siomi H, Siomi MC (2010) Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38:323-332
12. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
13. Lee Y, Ahn C, Han J et al (2003) The nuclear RNase III Drosha initiates micorRNA processing. Nature 425:415-419
14. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN (2004) The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18:3016-3027
15. Gregory RI, Yan KP, Amuthan G et al (2004) The microprocessor complex mediates the genesis of microRNAs. Nature 432:235-240
16. MacRae IJ, Ma E, Zhou M, Robinson CV, Doudna JA (2008) In vitro reconstitution of the human RISC-loading complex. Proc Natl Acad Sci USA 105:512-517
17. Ruby JG, Jan CH, Bartel DP (2007) Intronic microRNA precursors that bypass Drosha processing. Nature 448:83-86
18. Babiarz JE, Ruby JG, Wang Y, Bartel DP, Blelloch R (2008) Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, Dicer-dependent small RNAs. Genes Dev 22:2773-2785
19. Ender C, Krek A, Friedlander MR et al (2008) A human snoRNA with microRNA-like functions. Mol Cell 32:519-528
20. Miyoshi K, Miyoshi T, Siomi H (2010) Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. Mol Genet Genomics 284:95-103
21. Vasudevan S (2012) Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Rev RNA 3:311-330
22. Hashimoto Y, Akiyama Y, Yuasa Y (2013) Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS One 8:e62589
23. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597-610
24. Han J, Pederson JS, Kwon SC et al (2009) Posttranscriptional crossregulation between Drosha and DGCR8. Cell 136:75-84
25. Triboulet R, Chang HM, LaPierre RJ, Gregory RI (2009) Post-transcriptional control of DGCR8 expression by the microprocessor. RNA 15:1005-1011
26. Newman MA, Hammond SM (2010) Emerging paradigms of regulated microRNA processing. Genes Dev 24:1086-1092
27. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ (2001) Argonaute 2, a link between genetic and biochemical analyses of RNAi. Science 293:1146-1150
28. Heale BSE, Keegan LP, McGurk L et al (2009) Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J 28:3145-3156
29. Zhang Z, Qin YW, Brewer G, Jing Q (2012) MicroRNA degradation and turnover: regulating the regulators. Wiley Interdiscip Rev RNA 3:593-600
30. Sim SE, Bakes J, Kaang BK (2014) Neuronal activity-dependent regulation of microRNAs. Mol Cells 37:511-517
31. Lim LP, Lau NC, Garrett-Engele A, Grimson JM et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773
32. Esau C, Davis S, Murray SF, Yu XX, Pandey SK et al (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3:87-98
33. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226-230
34. Khalaj M, Tavakkoli M, Stranahan AW, Park CY (2014) Pathogenic microRNA's in myeloid malignancies. Front Genet 5:361
35. Simone NL, Soule BP, Ly D, Saleh AD et al (2009) Ionizing-induced oxidative stress alters miRNA expression. PLoS One 4:e6377
36. Kuss AW, Chen W (2008) MicroRNAs in brain function and disease. Curr Neurol Neurosci Rep 8:190-197
37. Sempere LF, Freemantle S, Pitha-Rowe I et al (2004) Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5:R13
38. Shi Y, Zhao X, Hsieh J, Wichterle H et al (2010) MicroRNA regulation of neural stem cells and neurogenesis. J Neurosci 30:14931-14936
39. Giraldez AJ, Cinalli RM, Glasner ME et al (2005) MicroRNAs regulate brain morphogenesis in zebrafish. Science 308:833-838
40. Chen JA, Wichterle H (2012) Apoptosis of limb innervating motor neurons and erosion of motor pool identity upon lineage specific dicer inactivation. Front Neurosci 6:69
41. Yang D, Li T, Wang Y et al (2012) miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J Cell Sci 125:1673-1682
42. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E et al (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317:1220-1224
43. Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N et al (2010) miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci USA 107:13111-13116
44. Schaefer A, O'Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R et al (2007) Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 204:1553-1558
45. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS (2006) Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 23:857-864
46. Conaco C, Otto S, Han JJ, Mandel G (2006) Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci USA 103:2422-2427
47. Makeyev EV, Zhang J, Carrasco MA, Maniatis T (2007) The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27:435-448
48. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M et al (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289
49. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA (2004) Molecular pathways to neurodegeneration. Nat Med 10(Suppl):S2-S9
50. Manakov SA, Grant SG, Enright AJ (2009) Reciprocal regulation of microRNAs and mRNA profiles in neuronal development and synapse formation. BMC Genom 10:419
51. Bruno IG, Karam R, Huang L et al (2011) Identification of microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell 42:500-510
52. Zhou R, Yuan P, Wang Y et al (2009) Evidence of selective microRNAs and their effectors as common long-term targets for the action of mood stabilizers. Neuropsychopharmacology 34:1395-1405
53. Gao J, Wang WY, Mao YW et al (2010) A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466:1105-1109
54. Olde Loohuis NF, Kos A, Martens GJ et al (2012) MicroRNA networks direct neuronal development and plasticity. Cell Mol Life Sci 69:89-102
55. Margis R, Margis R, Rieder CR (2011) Identification of blood microRNAs associated to Parkinson's disease. J Biotechnol 152:96-101
56. Geekiyanage H, Jicha GA, Nelson PT, Chan C (2012) Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp Neurol 235:491-496
57. Vallelunga A, Ragusa M, DiMauro S et al (2014) Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and multiple system atrophy. Front Cell Neurosci 8:156
58. Hébert SS, Horré K, Nicolaï L et al (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression. Proc Natl Acad Sci USA 105:6415-6420
59. Lee ST, Chu K, Im WS (2011) Altered microRNA regulation in Huntington's disease models. Exp Neurol 227:172-179
60. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT (2011) Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121:193-205
61. Geekiyanage H, Chan C (2011) MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J Neurosci 31:14820-14830
62. Abdullah R, Basak I, Patil KS, Alves G, Larsen JP, Moller SG (2014) Parkinson's disease and age: the obvious but largely unexplored link. Exp Gerontol 68:33-38
63. Inukai S, de Lencastre A, Turner M, Slack F (2012) Novel microRNAs differentially expressed during aging in the mouse brain. PLoS One 7:e40028
64. Persengiev S, Kondova I, Otting N, Koeppen AH, Bontrop RE (2011) Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis. Neurobiol Aging 32:e2317-e2327
65. Elfenbein HA, Rosen RF, Stephens SL et al (2007) Cerebral β-amyloid angiopathy in aged squirrel monkeys. Histol Histopathol 22:155-167
66. Martinez I, Almstead LL, DiMaio D (2011) MicroRNAs and senescence. Aging 3:77-78
67. Li X, Khanna A, Li N, Wang E (2011) Circulatory miR34a as an RNA based, noninvasive biomarker for brain aging. Aging 3:985-1002
68. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT et al (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169-3179
69. Smit-McBride Z, Forward KI, Nguyen AT (2014) Age-dependent increase in miR-34a expression in the posterior pole of the mouse eye. Mol Vis 20:1569-1578
70. Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM (2013) Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson's disease. Cell Death Dis 4:e545
71. Cardo LF, Coto E, Ribacoba R, Menéndez M, Moris G, Suárez E, Alvarez V (2014) MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects. J Mol Neurosci 54:830-836
72. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B et al (2008) Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14:27-41
73. Burgos K, Malenica I, Metpally R et al (2014) Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One 9:e94839
74. Lukiw WJ (2007) MiRNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport 18:297-300
75. Saba R, Goodman CD, Huzarewich RLCH, Robertson C, Booth SA (2008) A miRNA signature of prion induced neurodegeneration. PLoS One 3:e3652
76. Montag J, Hitt R, Opitz L (2009) Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol Neurodegener 4:36
77. Bellingham SA, Coleman BM, Hill AF (2012) Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res 40:10937-10949
78. Cummings CJ, Zoghbi HY (2000) Fourteen and counting: unravelling trinucleotide repeat diseases. Hum Mol Genet 9:909-916
79. Everett CM, Wood NW (2004) Trinucleotide repeats and neurodegenerative disease. Brain 127:2385-2405
80. Pogue AI, Cui JG, Li YY, Chao Y, Culicchia F, Lukiw WJ (2010) MicroRNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 476:18-22
81. Marti E, Pantano L, Banez-Coronel M et al (2010) A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res 38:7219-7235
82. Johnson R, Buckley NJ (2009) Gene dysregulation in Huntington's disease: REST, microRNAs and beyond. Neuromol Med 11:183-199
83. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL (2008) The bifunctional microRNA miR-9/miR-9∗regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 28:14341-14346
84. Basu U, Guan LL, Moore SS (2012) Functional genomics approach or identification of molecular processes underlying neurodegenerative disorders in prion diseases. Curr Genomics 13:369-378
85. Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14:457-487
86. Lynch-Day MA, Mao K, Wang K, Zhao M, Klionsky DJ (2012) The role of autophagy in Parkinson's disease. Cold Spring Harb Perspect Med 2:a009357
87. Schapira AH, Gegg M (2011) Mitochondrial contribution to Parkinson's disease pathogenesis. Parkinsons Dis 2011:159160
88. Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P, Voinnet O (2012) Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol 14:1314-1321
89. Majeski AE, Dice JF (2004) Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 36:2435-2444
90. Yang J, Chen D, He Y et al (2013) MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age 35:11-22
91. Zhu H, Wu H, Liu X et al (2009) Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 5:816-823
92. Williams AH, Valdez G, Moresi V et al (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326:1549-1554
93. Roccaro AM, Sacco A, Jia X et al (2010) microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood 116:1506-1514
94. Gilad S, Meiri E, Yogev Y et al (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3:e3148
95. Chen X, Ba Y, Ma L et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997-1006
96. Lang AE, Lozano AM (1998) Parkinson's disease - first of two parts. N Engl J Med 339:1044-1053
97. Martins M, Rosa A, Guedes LC et al (2011) Convergence of miRNA expression profiling, α-synuclein interaction and GWAS in Parkinson's disease. PLoS One 6:e25443
98. Khoo SK, Petillo D, Kang UJ et al (2012) Plasma-based circulating microRNA biomarkers for Parkinson's disease. J Parkinsons Dis 2:321-331
99. Schipper HM, Maes OC, Chertkow HM, Wang E (2007) microRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Biol 1:263-274
100. Leidinger P, Backes C, Deutscher S et al (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14:R78
101. Kumar P, Dezso Z, MacKenzie C et al (2013) Circulating miRNA biomarkers for Alzheimer's disease. PLoS One 8:e69807
102. De Felice B, Guida M, Guida M, Coppola C, de Mieri G, Cotrufo RA (2012) miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 508:35-40
103. Butovsky O, Siddiqui S, Gabriely G et al (2012) Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Investig 122:3063-3087
104. Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM (2009) Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 106:13052-13057
105. Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 285:12726-12734
106. Gehrke S, Imai Y, Sokol N, Lu B (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466:637-641
107. Cho HJ, Liu G, Jin SM et al (2014) MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22:608-620
108. Miñones-Moyano E, Porta S, Escaramís G et al (2011) MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet 20:3067-3078
109. Dickson JR, Kruse C, Montagna DR, Finsen B, Wolfe MS (2013) Alternative polyadenylation and miR-34 family members regulate tau expression. J Neurochem 127:739-749
110. Long JM, Lahiri DK (2011) MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 404:889-895
111. Liu W, Liu C, Zhu J et al (2012) MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiol Aging 33:522-534
112. Patel N, Hoang D, Miller N et al (2008) MicroRNAs can regulate human APP levels. Mol Neurodegener 3:10
113. Delay C, Calon F, Mathews P, Hébert SS (2011) Alzheimer-specific variants in the 3′UTR of Amyloid precursor protein affect microRNA function. Mol Neurodegener 6:70
114. Li YY, Cui JG, Hill JM, Bhattacharjee S, Zhao Y et al (2011) Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci Lett 487:94-98
115. Hu YK, Wang X, Li L, Du YH, Ye HT, Li CY (2013) MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1. Neurosci Bull 29:745-775
116. Wang WX, Wilfred BR, Madathil SK (2010) miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 177:334-345
117. Fang M, Wang J, Zhang X et al (2012) The miR-124 regulates the expression of BACE1/p-secretase correlated with cell death in Alzheimer's disease. Toxicol Lett 209:94-105
118. Cheng PH, Li CL, Chang YF et al (2013) miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models. Am Hum Genet 93:306-312
119. Rademakers R, Eriksen JL, Baker M et al (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17:3631-3642
120. Jiang J, Lee EJ, Gusev Y, Schmittgen TD (2005) Real-time expression profiling of microRNA precursors in human cancer cells. Nucleic Acids Res 33:5394-5403
121. Lu DP, Read RL, Humphreys DT, Battah FM, Martin DI, Rasko JE (2005) PCR-based expression analysis and identification of microRNAs. J RNAi Gene Silencing 1:44-49
122. Chen C, Ridzon DA, Broomer AJ et al (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179
123. Soreq L, Salomonis N, Bronstein M et al (2013) Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes. Front Mol Neurosci 6:10
124. Wang Z (2009) miRNA mimic technology. miRNA interference technologies. Springer, Berlin Heidelberg, pp 93-100
125. Boutla A, Delidakis C, Tabler M (2003) Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res 31:4973-4980
126. Hutvagner G, Simard MJ, Mello CC, Zamore PD (2004) Sequence-specific inhibition of small RNA function. PLoS Biol 2:E9
127. Vester B, Wengel J (2004) LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry 43:13233-13241
128. Koval ED, Shaner C, Zhang P et al (2013) Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet 22:4127-4135
129. Ebert MS, Neilson JR, Sharp PA (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721-726
130. Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z (2007) Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination of the pacemaker channel genes HCN2 and HCN4. J Cell Physiol 212:285-292
131. Tan H, Poidevin M, Li H, Chen D, Jin P (2012) MicroRNA-277 modulates the neurodegeneration caused by Fragile X premutation rCGG repeats. PLoS Genet 8:e1002681
132. Wang Z (2011) The principles of MiRNA-masking antisense oligonucleotide technology. Methods Mol Biol 676:43-49
133. Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A (2008) Small-molecular inhibitors of miR-21 function. Angew Chem Int Ed Engl 47:7482-7484
134. Serafin A, Foco L, Zanigni S et al (2015) Overexpression of blood microRNAs 103a, 30b, and 29a in l-dopa-treated patients with PD. Neurology 84:645-653
135. Garzon R, Marcucci G, Croce CM (2014) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9:775-789
136. Miller TM, Pestronk A, David W et al (2013) An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomized, first-in-man study. Lancet Neurol 12:435-442
137. Xu G, Fewell C, Taylor C et al (2010) Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq. RNA 16:1610-1622
138. Thomson DW, Bracken CP, Goodall GJ (2011) Experimental strategies for microRNA target identification. Nucleic Acids Res 39:6845-6853
139. Chi SW, Zang JB, Mele A, Darnell RB (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460:479-486
140. Hafner M, Landthaler M, Burger L et al (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141:129-141
141. Yang JH, Li JH, Jiang S, Zhou H, Qu LH (2013) ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and miRNA genes from ChIP-Seq data. Nucleic Acids Res 41:D177-D187
142. Li C, Xiong Q, Zhang J, Ge F, Bi LJ (2012) Quantitative proteomic strategies for the identification of microRNA targets. Expert Rev Proteomics 9:549-559
143. Kurata R, Yonezawa T, Nakajima H, Takada S, Asahara H (2012) LC-MS/MS-based shotgun proteomics identified the targets of arthritis related microRNA. Arthritis Res Ther 14:P36
144. Cardo LF, Coto E, de Mena L, Ribacoba R, Moris G, Menéndez M et al (2013) Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls. J Neurol 260:1420-1422
145. Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ (2012) microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 3:365-373
146. Shioya M, Obayashi S, Tabunoki H et al (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 36:320-330
147. Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Björkqvist M (2011) Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet 20:2225-2237
148. Lee ST, Chu K, Jung KH et al (2014) Altered expression of miR-202 in cerebellum of multiple-system atrophy. Mol Neurobiol 51:180-186
149. Campos-Melo D, Droppelmann CA, He Z, Volkening K, Strong MJ (2013) Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain 6:26
150. Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM, Junn E (2015) Inhibition of miR-34b and miR-34c enhances alpha-synuclein expression in Parkinson's disease. FEBS Lett 589:319-325
151. Wang G, van der Walt JM, Mayhew G et al (2008) Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 82:283-289
152. Asikainen S, Rudgalvyte M, Heikkinen L et al (2010) Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models. J Mol Neurosci 41:210-218
153. Delay C, Dorval V, Fok A et al (2014) MicroRNAs targeting Nicastrin regulate Aβ production and are affected by target site polymorphisms. Front Mol Neurosci 7:67
154. Yao J, Hennessey T, Flynt A, Lai E, Beal MF, Lin MT (2010) MicroRNA-related cofilin abnormality in Alzheimer's disease. PLoS One 5:e15546
155. Hebert SS et al (2009) MicroRNA regulation of Alzheimer's amyloid precursor protein expression. Neurobiol Dis 33:422-428